ELVN

Enliven Therapeutics Inc

NASDAQ · Pharmaceuticals

$29.42

+2.43 (+9.00%)

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

16 analysts

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +7.6% upside

Low Target $20.91

Average Target $31.67

High Target $36.06

Current Price $29.42

Current
$29.42

Target
$31.67

$20.91 $31.67 avg $36.06